idebenone has been researched along with Autosomal Dominant Optic Atrophy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Romagnoli, M | 1 |
La Morgia, C | 2 |
Carbonelli, M | 2 |
Di Vito, L | 1 |
Amore, G | 1 |
Zenesini, C | 1 |
Cascavilla, ML | 1 |
Barboni, P | 2 |
Carelli, V | 2 |
Smith, TG | 1 |
Seto, S | 1 |
Ganne, P | 1 |
Votruba, M | 1 |
Valentino, ML | 1 |
Savini, G | 1 |
De Negri, A | 1 |
Simonelli, F | 1 |
Sadun, F | 1 |
Caporali, L | 1 |
Maresca, A | 1 |
Liguori, R | 1 |
Baruzzi, A | 1 |
Zeviani, M | 1 |
1 trial available for idebenone and Autosomal Dominant Optic Atrophy
Article | Year |
---|---|
Idebenone treatment in patients with OPA1-mutant dominant optic atrophy.
Topics: Adult; Child; Cohort Studies; Female; Follow-Up Studies; GTP Phosphohydrolases; Humans; Male; Middle | 2013 |
2 other studies available for idebenone and Autosomal Dominant Optic Atrophy
Article | Year |
---|---|
Idebenone increases chance of stabilization/recovery of visual acuity in OPA1-dominant optic atrophy.
Topics: Adolescent; Adult; Antioxidants; Cohort Studies; Female; GTP Phosphohydrolases; Humans; Male; Middle | 2020 |
A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function.
Topics: Animals; Antioxidants; Blotting, Western; Dendrites; Disease Models, Animal; Female; GTP Phosphohydr | 2016 |